Published Date: 02 Mar 2023
High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.
Read Full NewsA single binge episode may precipitate acute gastric dilatation, a rare but life-threatening condition that clinicians can easily miss.
Amazon.com said on Thursday its pharmacy unit will stock Eli Lilly's new weight-loss pill at kiosks located at some of the company's primary care clinics and offer same-day...
The cervical biopsy was nondiagnostic despite imaging and PET suggesting aggressive disease; a targeted lumbar biopsy ultimately confirmed metastatic hepatocellular carcinoma.
Digital pathology AI is moving from detection to treatment decisions. In part 2 of this series, here’s what’s FDA-cleared — and how it changes care in oncology practice.
Communities are coming up with alternatives after the closing of several abortion clinics.
The acting director of the Centers for Disease Control and Prevention has delayed publication of a CDC report showing the COVID-19 vaccine cut the likelihood of...
Updated WHO guidance defines stage-based strategies for cystic echinococcosis, supporting imaging-driven diagnosis and individualized treatment choice.
1.
Contradictory Results Are Found in Two Pembrolizumab Trials for Head and Neck Cancer.
2.
Appropriate New Monoclonal for Immunocompromised Individuals to Prevent COVID-19.
3.
In myelofibrosis, combinations of rufolitinib reduce spleen volume.
4.
Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions
5.
Obesity linked to subsequent neoplasms in childhood cancer survivors
1.
Unveiling the Hidden Benefits of Lymphedema Treatment
2.
The New Frontier of Cancer Survivorship: Navigating the Long-Term Effects of Immunotherapy and Targeted Therapies
3.
Managing High Potassium Levels: A Comprehensive Guide to Veltassa
4.
The Latest Research on Chronic Granulomatous Disease and Promising New Treatments
5.
Cold Antibody AIHA and Neoplastic Disorders: Unraveling the Clinical and Pathogenic Link
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
2.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
3.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation